Cell and gene therapy

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the cell and gene therapy industry

This dossier presents key facts and figures about the cell and gene therapy industry. Cell and gene therapies are especially well-known in the treatment of cancer. The document provides information on the total market and submarkets, regional distribution, the cord blood bank system, forecasts, etc.

Table of contents

  • 1. Market overview
    • Global market size for regenerative medicine from 2016-2025

    • Global cell and gene therapy market forecast 2012-2020

    • Global cell culture market size 2012-2022

    • ATMP classification share worldwide 2016

    • Regenerative medicine companies by world region 2019

    • Market cap of larger gene and cell therapy companies in U.S. as of 2017

  • 2. R&D/trials
    • ATMP trials classification share by disease and development phase globally 2016

    • ATMP clinical trials share globally by type of sponsor

    • ATMP clinical trials non-commercial sponsors distribution globally 2016

    • Number of biotech therapies in development as of 2017, by developer

    • Percentage of biotech therapies in development as of 2017, by developer

  • 3. Stem cells
    • Global stem cell market size by world region 2011-2016

    • Stem cell technologies and applications market share by world region 2016

    • Global stem cell market size forecast 2025

    • Number of HSC transplants in the US from 2010-2015, by source

    • Total stem cell research funding by the National Institutes for Health 2013-2018

  • 4. Cord blood
    • Aggregate annual demand for cord blood units from 2010-2016

    • Annual social value of U.S. CBB system by scenario 2010-2016

    • Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016

    • Percentage of shipped U.S. cord blood units by TNC count 2002-2016

    • Percentage of stored U.S. CBUs by TNC count 2002-2016

  • 5. CAR/CAR-T
    • Number of CAR cell therapy trials worldwide 2007-2016

    • Number of CAR cell therapy trials U.S. vs China 2009-2016

    • Venture capital funding for companies in CAR-T programs 2011-2016

    • IPO value of select CAR-T companies 2013-2015

  • 6. Miscellaneous
    • Length of hospital stay for an HSC transplant in the U.S. in 2014, by procedure

    • Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure

    • Capital raised by regenerative medicine companies worldwide 2016-2018

    • Select market-stage ATMPs price in the U.S. as of 2016

    • View of increasing government funding for stem cell research - U.S. adults 2017

More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!